Literature DB >> 22537774

Long-lasting effects of chronic rTMS to treat chronic rodent model of depression.

Shu-fang Feng1, Tian-yao Shi, Wua-ning Wang, Yun-chun Chen, Qing-rong Tan.   

Abstract

Repetitive transcranial magnetic stimulation (rTMS) has been demonstrated in the pre-clinical and clinical settings to have an antidepressant effect. However, studies on the long-lasting effect of rTMS, especially when the effect is measured after treatment has ceased for a few weeks is lacking. We examined this question in a chronic unpredicted mild stress (CUMS) rat model of depression. We gave 3 weeks of high frequency (15 Hz) rTMS, venlafaxine, or these two treatments combined to a modified CUMS paradigm, and then investigated the prolonged effect of treatments. Behavioral testing (sucrose preference test, open field test, forced swimming test, novelty suppressed feeding test), plasma hormone level, hippocampal BrdU labeling, and amount of related neurotropic factors were used to assess the effects of stress and treatments. Long-term chronic rTMS significantly reversed andehonic-like behavior, increased hippocampus cell proliferation, BDNF protein level, phosphorylation of ERK1/2 compared with CUMS rats two weeks after the cessation of rTMS treatment. However, the changes in plasma hormone level were not sustained for that amount of time. Venlafaxine had no interaction with the physical stimulation. Our results suggest that high frequency rTMS has long-lasting effects, which may have some relationship with neuroplasticity.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22537774     DOI: 10.1016/j.bbr.2012.04.019

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  26 in total

1.  Regional alterations of cerebral [18F]FDG metabolism in the chronic unpredictable mild stress- and the repeated corticosterone depression model in rats.

Authors:  Nick Van Laeken; Glenn Pauwelyn; Robrecht Dockx; Benedicte Descamps; Boudewijn Brans; Kathelijne Peremans; Chris Baeken; Ingeborg Goethals; Christian Vanhove; Filip De Vos
Journal:  J Neural Transm (Vienna)       Date:  2018-06-28       Impact factor: 3.575

2.  Deep magnetic stimulation in a progressive supranuclear palsy patient with speech involvement.

Authors:  Francesca Spagnolo; Elisabetta Coppi; Pasquale Anthony Della Rosa; Mario Fichera; Alessandra Barbieri; Giuseppe Magnani; Monica Falautano; Abraham Zangen; Giancarlo Comi; Daniela Perani; Maria Antonietta Volontè; Letizia Leocani
Journal:  J Neurol       Date:  2012-12-02       Impact factor: 4.849

3.  Chronic mild stress eliminates the neuroprotective effect of Copaxone after CNS injury.

Authors:  Igor Smirnov; James T Walsh; Jonathan Kipnis
Journal:  Brain Behav Immun       Date:  2013-01-04       Impact factor: 7.217

Review 4.  The Current Situation on Major Depressive Disorder in China: Research on Mechanisms and Clinical Practice.

Authors:  Zhenghua Hou; Wenhao Jiang; Yingying Yin; Zhijun Zhang; Yonggui Yuan
Journal:  Neurosci Bull       Date:  2016-05-30       Impact factor: 5.203

5.  Effects of rTMS on Hippocampal Endocannabinoids and Depressive-like Behaviors in Adolescent Rats.

Authors:  Guoxiang Fang; Ying Wang
Journal:  Neurochem Res       Date:  2018-07-09       Impact factor: 3.996

Review 6.  Encore: Behavioural animal models of stress, depression and mood disorders.

Authors:  Aleksa Petković; Dipesh Chaudhury
Journal:  Front Behav Neurosci       Date:  2022-08-08       Impact factor: 3.617

Review 7.  Treatment-resistant depression: are animal models of depression fit for purpose?

Authors:  Paul Willner; Catherine Belzung
Journal:  Psychopharmacology (Berl)       Date:  2015-08-21       Impact factor: 4.530

8.  Differential effects of acute versus chronic stress on ethanol sensitivity: Evidence for interactions on both behavioral and neuroimmune outcomes.

Authors:  Tamara L Doremus-Fitzwater; Jacqueline E Paniccia; Anny Gano; Andrew S Vore; Terrence Deak
Journal:  Brain Behav Immun       Date:  2018-02-17       Impact factor: 7.217

9.  Rosmarinic acid ameliorates depressive-like behaviors in a rat model of CUS and Up-regulates BDNF levels in the hippocampus and hippocampal-derived astrocytes.

Authors:  Xiang Jin; Peng Liu; Fengchi Yang; Ya-Hong Zhang; Danmin Miao
Journal:  Neurochem Res       Date:  2013-06-12       Impact factor: 3.996

10.  Moving back in the brain to drive the field forward: Targeting neurostimulation to different brain regions in animal models of depression and neurodegeneration.

Authors:  Michelle R Madore; Eugenia Poh; Samuel John Bollard; Jesus Rivera; Joy Taylor; Jauhtai Cheng; Eric Booth; Monica Nable; Alesha Heath; Jerry Yesavage; Jennifer Rodger; M Windy McNerney
Journal:  J Neurosci Methods       Date:  2021-06-17       Impact factor: 2.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.